GUMM - Eliminate the Common Cold Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mad2 who wrote (2503)	4/13/2000 10:23:00 AM
From: Mike M	Read Replies (1) of 5582

Good technical call a couple months ago. We will see what the next few months of small cap underachieving does to small companies like GUMM... I reject your comparison to QGLY out of hand and fully expect to be vindicated on that issue. The success or failure of Zicam hinges IMO on a marketing issue and a science issue and not on any product similarity to QGLY. Other product rollouts should, IMO, further make the comparison a moot point. I do feel badly for those who margined heavily and have been forced to liquidate this and other small caps. You were certainly on the money regarding the stock's cyclical vulnerability. Congratulations.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next